Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2007
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1839669A1 Novel angiogensis inhibitor
10/03/2007EP1839657A2 A method for treating vascular headaches
10/03/2007EP1839653A1 Therapeutic agent for sensory abnormality
10/03/2007EP1839652A1 Agents to positively influence Alzheimer's disease and/or as an Alzheimer's prophylaxis
10/03/2007EP1839651A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
10/03/2007EP1839648A2 An inhalation system
10/03/2007EP1838854A2 Humanized antibodies that recognize beta amyloid peptide
10/03/2007EP1838716A1 Olanzapine pamoate dihydrate
10/03/2007EP1838714A1 Methods of treating pain
10/03/2007EP1838707A1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors
10/03/2007EP1838705A2 3,8-substituted 8-aza-bicyclo [3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/03/2007EP1838702A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
10/03/2007EP1838701A1 N-substituted heterocyclic sulfonamides
10/03/2007EP1838694A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators
10/03/2007EP1838687A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838686A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838685A1 Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838684A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators
10/03/2007EP1838680A2 Macrocyclic compounds and compositions useful as bace inhibitors
10/03/2007EP1838677A2 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
10/03/2007EP1838349A1 Amyloid beta antibodies for use in improving cognition
10/03/2007EP1838348A1 Humanized amyloid beta antibodies for use in improving cognition
10/03/2007EP1838325A1 NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f][1,4]THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS
10/03/2007EP1838318A1 Use of oxycodone for treating visceral pain
10/03/2007EP1838317A1 Analgesic conjugates
10/03/2007EP1838310A1 Combination of sabcomeline with a neuroleptic agent to treat psychotic disorders
10/03/2007EP1838308A1 [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
10/03/2007EP1838306A1 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
10/03/2007EP1838304A2 Heterocyclic aspartyl protease inhibitors
10/03/2007EP1838297A1 1-aminocyclohexane-derivatives for the treatment of multiple sclerosis emotional lability and pseudobulbar affect
10/03/2007EP1663232B1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
10/03/2007EP1622874B1 3,4-dihydro-1h-quinolin-2-one derivatives as norepinephrine reuptake inhibitors
10/03/2007EP1599167B1 Benzimidazole and imidazopyridine derivatives having affinity for the melanocortin receptors and use thereof as a medicament
10/03/2007EP1558219B1 Pharmaceutical formulation of olanzapine
10/03/2007EP1511722B1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
10/03/2007EP1490361B1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/03/2007EP1453909B1 Cereal beta glucan compositions, methods of preparation and uses thereof
10/03/2007EP1448530B1 Heteroaryl carboxylic acid amides
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1366161B1 Antagonist anti-pro842 antibody
10/03/2007EP1355940B1 Urotensin-ii agonists and antagonists
10/03/2007EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/03/2007EP1353672B1 Synthesis of 4-amino-thalidomide enantiomers
10/03/2007EP1351968B1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/03/2007EP1306093B1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
10/03/2007EP1304324B1 Serotonin reuptake inhibitors
10/03/2007EP1239865B1 Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract
10/03/2007EP1183232B1 Monofluoroalkyl derivatives
10/03/2007EP1042307B1 Aminothiazole inhibitors of cyclin dependent kinases
10/03/2007CN101048428A Methods of using death receptor ligands and CD20 antibodies
10/03/2007CN101048414A Fused tricyclic derivatives for the treatment of psychotic disorders
10/03/2007CN101048413A Thienopyridines as allosteric potentiators of the M4 muscarinic receptor
10/03/2007CN101048397A 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors
10/03/2007CN101048393A Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
10/03/2007CN101048392A Novel use
10/03/2007CN101048174A Composition comprising vlp and amyloid-beta peptide
10/03/2007CN101048166A Abnormal protein removing composition
10/03/2007CN101048164A Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
10/03/2007CN101045715A Heterocycle inhibitor for glycogen synthase kinase gsk-3
10/03/2007CN101045714A Amino-acid biphenyl compound and medicine usage thereof
10/03/2007CN101045708A Helicid hydrastine acetali mine its preparation method and its application
10/03/2007CN101045704A An improved process for preparing pure ondansetron hydrochloride dihydrate
10/03/2007CN101045137A Capsule for treating epilepsia and its preparing method
10/03/2007CN101045135A Medicine use for improving memory and treating senile dementia due to encephalatrophy
10/03/2007CN101045130A Health-care medicated pillow
10/03/2007CN101045122A Traditional Chinese medicine composition for tonifying-spleen and nourishing the stomach, and its preparing method
10/03/2007CN101045117A Traditional Chinese medicine cream for treating facial paralysis
10/03/2007CN101045107A Method for extracting pseudo-purslane saponin, and its application in medical field
10/03/2007CN101045087A Traditional Chinese medicine for improving memory of learning and preventing memory failing
10/03/2007CN101045084A Medicine for treating prolapse of lumber intervertebral disc and sciatica
10/03/2007CN101045083A Qingxuan soft capsule for clearing giddiness, its preparing method and quality control method
10/03/2007CN101045076A Extractive of persimmon leaves ethyl acetate used for prevention and/or treatment of glycolipid metabolism related diseases
10/03/2007CN101045072A Extractive of turnipia arguta leaves and its pharmaceutical use
10/03/2007CN101045051A Novel use of tizanidine or its derivatives
10/03/2007CN101044901A Beverage for helping to stop smoking
10/03/2007CN100340661C Bone marrow interstital stem cell preparation and its combined use with controlled release neurotrophic factor
10/03/2007CN100340573C Heterocarpine, human GHRH-binding protein
10/03/2007CN100340562C Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
10/03/2007CN100340561C Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
10/03/2007CN100340557C Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/03/2007CN100340554C Halogen substituted tetracyclic tetrahydrofuran derivatives
10/03/2007CN100340548C Novel arylheteroalkylamine derivatives
10/03/2007CN100340395C Multilaminate backing construction
10/03/2007CN100340294C Remedy for spinal injury containing interleukin-6 antagonist
10/03/2007CN100340288C Inhibitors for continuous activation of calcineurin
10/03/2007CN100340281C Sobering up infusion granule and preparation thereof
10/03/2007CN100340260C Method for preparing blood sugar-decreasing sleep-assisting intestine-benefiting oral liquid with micron mulberry leaf, hawthorn fruit, amber, pseudostellaria root and royal jelly
10/03/2007CN100340259C Method for preparing blood sugar-decreasing sleep-assisting intestine-benefiting capsule and powder with micron mulberry leaf, hawthorn fruit, amber, asiabell, royal jelly
10/03/2007CN100340256C Plaster for treating facial palsy and preparing method
10/03/2007CN100340253C Chinese medicinal composition for treating headache and its preparation method
10/03/2007CN100340189C Compound mormula folic acid nutrient supplementing preparation
10/02/2007US7276641 Mixture with analgesic and anti-inflammatory dissolved in an aqueous hot melt type adhesive base material of styrene-isoprene-styrene block copolymer, adhesive resin, an antioxidant, lanolin, and water; drug releasability, good bioavalability
10/02/2007US7276610 Aryl piperidine amides
10/02/2007US7276607 5-HT7 receptor antagonists
10/02/2007US7276603 serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer
10/02/2007US7276593 Proteins and nucleic acids encoding same
10/02/2007US7276580 Neurotrophic factors
10/02/2007US7276528 Compounds for the inhibition of nitric oxide synthase
1 ... 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 ... 1833